Parsyl utilizes its commercial technology to solve major global health challenges.
Global vaccination coverage is at 85%, the highest it has ever been. Yet barriers in the global health supply chain persist.
Vaccines require a temperature controlled supply chain to maintain effectiveness, and unreliable transportation systems and storage facilities in developing countries make it difficult to maintain necessary conditions.
Accidental freezing of vaccines is a growing threat and a real risk for international immunization programs.
Some immunization programs may even be unknowingly vaccinating their population with vaccines that have lost potency.
Freeze-sensitive vaccines procured
through UNICEF in 2015 totaled
of vaccines in lower income countries are exposed to temperatures below recommended ranges during storage
"...vaccines can travel thousands of miles across the world to reach remote communities in Africa and Asia, but if they become too hot or too cold during that very last mile all the effort is for naught. That’s why this partnership with Parsyl is so important, ensuring that countries are using the latest technology to keep these vaccines effective."Dr. Seth Berkley CEO of Gavi
Parsyl provides actionable insights derived from real data about environmental conditions experienced by vaccines during shipment and in storage - from the first mile to the last - to inform and encourage supply chain best practices.
Intuitive sensing devices and mobile app allow frontline health workers to easily understand the quality of vaccines prior to immunization, even in last mile locations.
Powerful insights gained from Parsyl's combined hardware and software solution offer greater visibility into causes and location of product degradation.
Parsyl's robust data analysis allows global health partners to make data driven decisions about future shipment and storage methods to ensure vaccines remain safe and effective.
At Parsyl, we know the journey matters. We've entered into a public-private partnership with Gavi, the world's largest funder of childhood vaccines for developing countries, to address these supply chain challenges by monitoring critical vaccine deliveries around the world. Today, Parsyl is monitoring HPV vaccines funded by Gavi and the government of Senegal that will reach over 1 million Senegalise girls, in efforts to reduce rates of cervical cancer, a leading cause of cancer death among women in low and lower-middle-income countries.
Gavi expects to immunize 300 million children between 2016 and 2020 and avert 5-6 million future deaths through its support for routine immunization programs and vaccination campaigns.